All In Biotech

Drug Trial Radar · NCT00029822

Clinical Trial in Males With BPH (Enlarged Prostate)

Long-Term, Efficacy and Safety of Alfuzosin 10 MG OD on the Risk of Acute Urinary Retention and the Need for Surgery in Patients With BPH. A Two Year, Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Study.

Last checked: Nov 20, 2026Latest source record: Jun 9, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,522 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,522

Actual

Start

May 2001

Primary completion

Not stated

Study completion Mar 2005

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Jan 24, 2002

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
Male only, from 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to determine the effect on prevention of Acute Urinary Retention (inability to urinate) in males with an enlarged prostate, also known as BPH. * Free study-related medical care provided.

Conditions

  • Urinary Retention
  • Prostatic Hyperplasia
  • Benign Prostatic Hypertrophy

Interventions

  • Alfuzosin (SL770499)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. occurrence of first episode of acute urinary retention (AUR)

Locations

54 sites in 17 countries. Site status is shown where the registry gives one.

  • Medical Affiliated Research Center, Inc

    Huntsville, Alabama

  • San Diego Urology Center

    La Mesa, California

  • San Bernardino Urology Associates

    San Bernardino, California

  • San Diego Urological Medical Group

    San Diego, California

  • Pacific Clinical Research

    Santa Monica, California

  • Urology Research Options

    Aurora, Colorado

  • Connecticut Clinical Research Center

    Waterbury, Connecticut

  • South Florida Medical Research

    Aventura, Florida

  • Tampa Bay Medical Research, Inc.

    Clearwater, Florida

  • Advanced Research Institute

    New Port Richey, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Renstar Medical Research

    Plantation, Florida

  • Urology Associates

    Marietta, Georgia

  • Northwestern Center for Clinical Research

    Chicago, Illinois

  • Welborn Clinic

    Evansville, Indiana

  • Northeast Indiana Research

    Fort Wayne, Indiana

  • Urology of Indiana, LLC

    Indianapolis, Indiana

  • Maryland Prostate Cancer

    Baltimore, Maryland

  • Maryland Urology Association

    Towson, Maryland

  • Newton Wellesley Urology

    Newton, Massachusetts

  • Lakeside Urology, P.C.

    Saint Joseph, Michigan

  • Se Urology Network

    Southaven, Mississippi

  • Weill Cornell Medical Center

    New York, New York

  • Advanced Clinical Trials

    Eugene, Oregon

  • Albert Einstein Medical Center

    Philadelphia, Pennsylvania

  • Center for Urologic Care

    West Reading, Pennsylvania

  • Matrix Research

    Greenville, South Carolina

  • Ut Medical Group, Inc.

    Memphis, Tennessee

  • Murfreesboro Medical Center

    Murfreesboro, Tennessee

  • nTouch Research Corporation

    Dallas, Texas

  • Urology Consultants, P.A.

    San Antonio, Texas

  • Urology Associates

    Fredericksburg, Virginia

  • Jeffrey Frankel

    Seattle, Washington

  • University of Wisconsin Hospital & Clinics

    Madison, Wisconsin

  • Midwest Research Specialists, LLC

    Milwaukee, Wisconsin

  • Sanofi-aventis Administrative Office

    Macquarie Park, Australia

  • Sanofi-aventis Administrative Office

    Sofia, Bulgaria

  • Sanofi-aventis Administrative Office

    Laval, Canada

  • Sanofi-aventis Administrative Office

    Hørsholm, Denmark

  • Sanofi-aventis Administrative Office

    Helsinki, Finland

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.